Efficacy and Safety of a 24-Hour Wearable Insulin Delivery Device for Basal-Bolus Therapy in Older Adults

被引：0
|
作者：
Zeidan, Trisha
Nikkel, Carla C.
Dziengelewski, Elizabeth A.
机构：
来源：
DIABETES | 2019年 / 68卷
关键词：
D O I：
10.2337/db19-1045-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1045-P
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Safety and efficacy of insulin aspart vs. regular human insulin in basal/bolus therapy for patients with gestational diabetes
    Jovanovic, L
    Howard, C
    Pettitt, D
    Zisser, H
    Ospina, P
    [J]. DIABETES, 2005, 54 : A675 - A675
  • [32] PaQ®, an easy-to-use Insulin Delivery Device to the Basal/Bolus Therapy for Patients with Type 2 Diabetes
    Kojzar, Harald
    Mader, Julia K.
    Aberer, Felix
    Lilly, Leslie C.
    Korsatko, Stefan
    Damsbo, Peter
    Pieber, Thomas R.
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2013, 125 : S9 - S10
  • [33] PaQ®, an easy-to-use Insulin Delivery Device to the Basal/Bolus Therapy for Patients with Type 2 Diabetes
    Hermanns, Norbert
    Mader, Julia K.
    Lilly, Leslie C.
    Aberer, Felix
    Kojzar, Harald
    Korsatko, Stefan
    Warner, Jay
    Pieber, Thomas R.
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2013, 125 : S8 - S9
  • [34] Efficacy, Usability and Sequence of Operations of a Workflow-Integrated Algorithm for Basal-Bolus Insulin Therapy in Hospitalized Type 2 Diabetes Patients
    Mader, Julia K.
    Neubauer, Katharina M.
    Schaupp, Lukas
    Augustin, Thomas
    Beck, Peter
    Spat, Stephan
    Hoell, Bernhard
    Treiber, Gerlies
    Fruhwald, Friedrich
    Pieber, Thomas R.
    Plank, Johannes
    [J]. DIABETES, 2013, 62 : A81 - A81
  • [35] Efficacy, usability and sequence of operations of a workflow-integrated algorithm for basal-bolus insulin therapy in hospitalized type 2 diabetes patients
    Mader, J. K.
    Neubauer, K. M.
    Schaupp, L.
    Augustin, T.
    Beck, P.
    Spat, S.
    Hoell, B.
    Treiber, G. M.
    Fruhwald, F. M.
    Pieber, T. R.
    Plank, J.
    [J]. DIABETES OBESITY & METABOLISM, 2014, 16 (02): : 137 - 146
  • [36] VALIDATION OF ADHESIVE TAPE OPTIMIZATION OF PAQ, A SIMPLE, THREE-DAY WEARABLE BASAL/BOLUS INSULIN DELIVERY DEVICE, IN NORMAL VOLUNTEERS
    Yablonski, M.
    Arsenault, J.
    Barnett, K.
    Brodeur, C.
    Cropp, A.
    Shelsky, J.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2016, 18 : A122 - A122
  • [37] Insulin aspart vs. regular human insulin in basal/bolus therapy for patients with gestational diabetes mellitus: safety and efficacy
    Jovanovic, L
    Howard, C
    Pettitt, D
    Zisser, H
    Ospina, P
    [J]. DIABETOLOGIA, 2005, 48 : A317 - A318
  • [38] A randomized trial comparing the efficacy and safety of treating patients with type 2 diabetes and highly elevated HbA1c levels with basal-bolus insulin or a glucagon-like peptide-1 receptor agonist plus basal-bolus insulin: The SIMPLE study
    Abreu, Marconi
    Tumyan, Anna
    Elhassan, Ahmed
    Peicher, Katherine
    Papacostea, Olivia
    Dimachkie, Perihan
    Siddiqui, Muhammad S.
    Pop, Laurentiu M.
    Gunasekaran, Uma
    Meneghini, Luigi F.
    Adams-Huet, Beverley
    Li, Xilong
    Lingvay, Ildiko
    [J]. DIABETES OBESITY & METABOLISM, 2019, 21 (09): : 2133 - 2141
  • [39] REAL- WORLD EFFICACY AND SAFETY OF INSULIN DEGLUDEC, AN ULTRA-LONG ACTING BASAL INSULIN, IN BASAL-BOLUS TREATMENT WITH MEALTIME RAPID ACTING INSULIN IN TYPE 1 DIABETES IN INDIAN PEDIATRIC POPULATION
    Sethi, Aashish
    Kochar, Inderpal S.
    [J]. HORMONE RESEARCH IN PAEDIATRICS, 2017, 88 : 612 - 613
  • [40] Comparable Efficacy and Safety of Insulin Glulisine and Insulin Lispro When Given as Part of a Basal-Bolus Insulin Regimen in a 26-Week Trial in Pediatric Patients with Type 1 Diabetes
    Philotheou, Areti
    Arslanian, Silva
    Blatniczky, Laszlo
    Peterkova, Valentina
    Souhami, Elisabeth
    Danne, Thomas
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2011, 13 (03) : 327 - 334
12345